Effect of ozone therapy in post COVID-19 lung sequels
Not Applicable
- Conditions
- Condition 1: Post COVID fibrosis/ inflammatory lung disease. Condition 2: COVID-19 disease.Abnormal findings on diagnostic imaging of lungCOVID-19, virus identifiedU07.1
- Registration Number
- IRCT20220814055690N1
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 206
Inclusion Criteria
Filling out the informed consent form
Post COVID-19 oxygen dependent patients
Exclusion Criteria
Hypersensitivity to ozone
Albumin less than 3.4
Platelets less than 60,000
Bleeding and coagulation disorders
Uncontrolled hyperthyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of improvement of pulmonary involvement in CT scan reports of patients. Timepoint: At the beginning of the study and 6 months after the received treatment. Method of measurement: CT scan report of patients.;Spirometry diagram. Timepoint: At the beginning of the study and 6 months after the received treatment. Method of measurement: Interpretation of spirometry.
- Secondary Outcome Measures
Name Time Method